Abstract
The affinity of the nonpeptide antagonist OPC-21268 is greater for the rat V1 arginine vasopressin (AVP) receptor (V1R) than for the human V1R. Site-specific mutagenesis was carried out to identify the residues that determine interspecies selectivity for nonpeptide antagonist binding. The introduction of rat amino acids in position 224, 310, 324, or 337 of the human V1R sequence dramatically altered OPC-21268 affinity for the receptor, whereas binding of AVP, the peptide V1R antagonist d(CH2)5Tyr(Me)AVP, and the nonpeptide V1R antagonist SR49059 was not altered by these mutations. Computer modeling explained the mutagenesis results. Docking of OPC-21268 onto a homology-built model of the V1R receptor yielded a model for the bound ligand in which the hydrophobic part is deeply embedded in the transmembrane region, whereas the polar part is located on the surface of the extracellular side. The increased affinity of the G337A mutant is due to two additional van der Waals contacts of the alanine methyl group with carbon atoms on the antagonist. The I310V mutant reduces the hydrophobicity in the vicinity of the polar oxygen atom of the antagonist. The I224V mutant relieves overcrowding in a hydrophobic binding pocket involving the aromatic residues Trp175, Phe179, Phe307, and Trp304. Finally, the E324D mutant enables the formation of a hydrogen bond of the carboxylate side chain with the amide side chain of Gln311, which in turn forms a hydrogen bond with the N57 nitrogen atom of OPC-21268. Thus, a few residues, distinct from those involved in agonist binding, control interspecies selectivity toward OPC-21268 nonpeptide antagonist binding.
Footnotes
-
Send reprint requests to: Dr. Marc Thibonnier, Room BRB431, Division of Clinical and Molecular Endocrinology, Department of Medicine, Case Western Reserve University School of Medicine, 10900 Euclid Ave., Cleveland, OH 44106-4951. E-mail:mxt10{at}po.cwru.edu
-
↵1 This work was supported in part by National Institutes of Health Grants RO1-HL39757 and PO1-HL41618. P.C. was supported by an Undergraduate Research Experience supplement to Grant MCB97-28420 from the National Science Foundation awarded to M.S.
- Abbreviations:
- AVP
- arginine vasopressin
- OT
- oxytocin
- V1R
- V1 vascular vasopressin receptor
- V2R
- V2 renal vasopressin receptor
- V3R
- V3 pituitary vasopressin receptor
- GPCR
- G protein-coupled receptor
- CHO
- Chinese hamster ovary
- TMS
- transmembrane segment
- Received December 8, 1999.
- Accepted March 14, 2000.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|